Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Change in Cash (2021 - 2026)

HeartSciences' Change in Cash history spans 6 years, with the latest figure at $1.4 million for Q1 2026.

  • For Q1 2026, Change in Cash rose 199.34% year-over-year to $1.4 million; the TTM value through Jan 2026 reached $800513.0, up 117.87%, while the annual FY2025 figure was -$4.7 million, 213.56% down from the prior year.
  • Change in Cash reached $1.4 million in Q1 2026 per HSCS's latest filing, up from -$841128.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $7.0 million in Q1 2024 to a low of -$1.5 million in Q2 2025.
  • Average Change in Cash over 5 years is $178038.6, with a median of -$475510.0 recorded in 2023.
  • Peak YoY movement for Change in Cash: crashed 428.37% in 2022, then skyrocketed 709.28% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$1.2 million in 2022, then surged by 60.26% to -$475510.0 in 2023, then soared by 39.51% to -$287658.0 in 2024, then crashed by 192.41% to -$841128.0 in 2025, then surged by 271.9% to $1.4 million in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Change in Cash are $1.4 million (Q1 2026), -$841128.0 (Q4 2025), and $1.7 million (Q3 2025).